Targeting STAT3 has Therapeutic Potential to regain Nilotinib response in parental and Resistant Chronic Myeloid Leukemia Cells
Conference paper > Summary Text · 2015
Authors: Burçin KAYMAZ, Nur SELVİ GÜNEL, Vildan BOZOK, AYSUN ADAN GÖKBULUT, YUSUF BARAN, Cumhur GÜNDÜZ, Buket KOSOVA
3rd EACR-Sponsored Anticancer Agent Development Congress, International, Summary Text, 2015-2015